nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR1—GPCR ligand binding—ADM—autistic disorder	0.00165	0.00165	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—AVP—autistic disorder	0.00165	0.00165	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	0.00164	0.00164	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—OXTR—autistic disorder	0.00163	0.00163	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SCT—autistic disorder	0.00161	0.00161	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—ADRB2—autistic disorder	0.00159	0.00159	CbGpPWpGaD
Tasosartan—AGTR1—G alpha (q) signalling events—HTR2A—autistic disorder	0.00157	0.00157	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—OPRM1—autistic disorder	0.00156	0.00156	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	0.00155	0.00155	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR5A—autistic disorder	0.00155	0.00155	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GABBR1—autistic disorder	0.00154	0.00154	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADM—autistic disorder	0.00154	0.00154	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EIF4E—autistic disorder	0.00151	0.00151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDE4B—autistic disorder	0.0015	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—AVP—autistic disorder	0.0015	0.0015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—OPRM1—autistic disorder	0.00145	0.00145	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GABBR2—autistic disorder	0.00145	0.00145	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PLA2G4A—autistic disorder	0.00141	0.00141	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—autistic disorder	0.0014	0.0014	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—OXT—autistic disorder	0.00139	0.00139	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR1B—autistic disorder	0.00139	0.00139	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—HTR2A—autistic disorder	0.00137	0.00137	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—GZMB—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GABBR2—autistic disorder	0.00132	0.00132	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR1D—autistic disorder	0.00129	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—OXT—autistic disorder	0.00129	0.00129	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR1B—autistic disorder	0.00129	0.00129	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD1—autistic disorder	0.00129	0.00129	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.00125	0.00125	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—DRD3—autistic disorder	0.00125	0.00125	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	0.00125	0.00125	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HTR2A—autistic disorder	0.00124	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—POMC—autistic disorder	0.00124	0.00124	CbGpPWpGaD
Tasosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	0.00121	0.00121	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CALCA—autistic disorder	0.00121	0.00121	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PRKCB—autistic disorder	0.0012	0.0012	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRM8—autistic disorder	0.0012	0.0012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD1—autistic disorder	0.0012	0.0012	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC1—autistic disorder	0.0012	0.0012	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR1D—autistic disorder	0.00117	0.00117	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK2—autistic disorder	0.00117	0.00117	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—DRD3—autistic disorder	0.00116	0.00116	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CYP19A1—autistic disorder	0.00116	0.00116	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—PIK3CG—autistic disorder	0.00115	0.00115	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL5—autistic disorder	0.00114	0.00114	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PDE4A—autistic disorder	0.00113	0.00113	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CALCA—autistic disorder	0.00112	0.00112	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—POMC—autistic disorder	0.00109	0.00109	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PRKCB—autistic disorder	0.00109	0.00109	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRM8—autistic disorder	0.00109	0.00109	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM5—autistic disorder	0.00108	0.00108	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM5—autistic disorder	0.00106	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AVPR1A—autistic disorder	0.00106	0.00106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—WNT2—autistic disorder	0.00106	0.00106	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—PIK3CG—autistic disorder	0.00104	0.00104	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CAT—autistic disorder	0.00104	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	0.00104	0.00104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4A—autistic disorder	0.00103	0.00103	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—VIP—autistic disorder	0.00102	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GRM5—autistic disorder	0.00102	0.00102	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB2—autistic disorder	0.00101	0.00101	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—POMC—autistic disorder	0.000994	0.000994	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRL—autistic disorder	0.000992	0.000992	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OXTR—autistic disorder	0.00099	0.00099	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—SCT—autistic disorder	0.00098	0.00098	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AVPR1A—autistic disorder	0.000961	0.000961	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NRP2—autistic disorder	0.000954	0.000954	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—AVP—autistic disorder	0.00095	0.00095	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB2—autistic disorder	0.000941	0.000941	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	0.000935	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADM—autistic disorder	0.000935	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—GABBR1—autistic disorder	0.000935	0.000935	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GRM5—autistic disorder	0.000928	0.000928	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—VIP—autistic disorder	0.000928	0.000928	CbGpPWpGaD
Tasosartan—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	0.000923	0.000923	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR5A—autistic disorder	0.000915	0.000915	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PDE4B—autistic disorder	0.000911	0.000911	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OXTR—autistic disorder	0.000899	0.000899	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—SCT—autistic disorder	0.00089	0.00089	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AVP—autistic disorder	0.000884	0.000884	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OPRM1—autistic disorder	0.000882	0.000882	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF2—autistic disorder	0.00088	0.00088	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADM—autistic disorder	0.000849	0.000849	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—GABBR1—autistic disorder	0.000849	0.000849	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PLA2G4A—autistic disorder	0.000831	0.000831	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	0.000829	0.000829	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4B—autistic disorder	0.000827	0.000827	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—autistic disorder	0.000809	0.000809	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MEF2C—autistic disorder	0.000808	0.000808	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OPRM1—autistic disorder	0.000801	0.000801	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—HTR2A—autistic disorder	0.00079	0.00079	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ITGB3—autistic disorder	0.000788	0.000788	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR1B—autistic disorder	0.000783	0.000783	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—OXT—autistic disorder	0.000783	0.000783	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GABBR2—autistic disorder	0.000778	0.000778	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.000758	0.000758	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HTR2A—autistic disorder	0.000735	0.000735	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—autistic disorder	0.000735	0.000735	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD1—autistic disorder	0.000728	0.000728	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR1B—autistic disorder	0.000711	0.000711	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—OXT—autistic disorder	0.000711	0.000711	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—DRD3—autistic disorder	0.000705	0.000705	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.0007	0.0007	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TSC2—autistic disorder	0.000699	0.000699	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR1D—autistic disorder	0.000693	0.000693	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL5—autistic disorder	0.00069	0.00069	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APOE—autistic disorder	0.000684	0.000684	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LEP—autistic disorder	0.000684	0.000684	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CALCA—autistic disorder	0.000682	0.000682	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRLR—autistic disorder	0.000668	0.000668	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MAOB—autistic disorder	0.000665	0.000665	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD1—autistic disorder	0.000661	0.000661	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM8—autistic disorder	0.000645	0.000645	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PRKCB—autistic disorder	0.000645	0.000645	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—DRD3—autistic disorder	0.00064	0.00064	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—autistic disorder	0.000633	0.000633	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—POMC—autistic disorder	0.000631	0.000631	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL5—autistic disorder	0.000627	0.000627	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—WNT2—autistic disorder	0.000624	0.000624	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CALCA—autistic disorder	0.000619	0.000619	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—APC—autistic disorder	0.000617	0.000617	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PIK3CG—autistic disorder	0.000617	0.000617	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GHR—autistic disorder	0.000615	0.000615	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGF—autistic disorder	0.00061	0.00061	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4A—autistic disorder	0.000606	0.000606	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—POMC—autistic disorder	0.000587	0.000587	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB2—autistic disorder	0.000571	0.000571	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVPR1A—autistic disorder	0.000568	0.000568	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IGF1—autistic disorder	0.000565	0.000565	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—MAPK1—autistic disorder	0.000562	0.000562	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	0.000562	0.000562	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VIP—autistic disorder	0.000548	0.000548	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GRM5—autistic disorder	0.000548	0.000548	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AVP—autistic disorder	0.000537	0.000537	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—autistic disorder	0.000536	0.000536	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OXTR—autistic disorder	0.000531	0.000531	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SCT—autistic disorder	0.000526	0.000526	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB2—autistic disorder	0.000519	0.000519	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—autistic disorder	0.000508	0.000508	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADM—autistic disorder	0.000501	0.000501	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GABBR1—autistic disorder	0.000501	0.000501	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EIF4E—autistic disorder	0.000493	0.000493	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4B—autistic disorder	0.000489	0.000489	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AVP—autistic disorder	0.000487	0.000487	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—autistic disorder	0.000486	0.000486	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OPRM1—autistic disorder	0.000473	0.000473	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PLA2G4A—autistic disorder	0.000458	0.000458	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.000456	0.000456	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—HRAS—autistic disorder	0.000451	0.000451	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—HTR2A—autistic disorder	0.000447	0.000447	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—autistic disorder	0.000434	0.000434	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—GZMB—autistic disorder	0.000433	0.000433	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—autistic disorder	0.000432	0.000432	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—OXT—autistic disorder	0.00042	0.00042	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR1B—autistic disorder	0.00042	0.00042	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—autistic disorder	0.000409	0.000409	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HTR2A—autistic disorder	0.000406	0.000406	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—CYP19A1—autistic disorder	0.000403	0.000403	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—CYP19A1—autistic disorder	0.000397	0.000397	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PRKCB—autistic disorder	0.000392	0.000392	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC1—autistic disorder	0.000391	0.000391	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD1—autistic disorder	0.000391	0.000391	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK2—autistic disorder	0.00038	0.00038	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—DRD3—autistic disorder	0.000378	0.000378	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PIK3CG—autistic disorder	0.000375	0.000375	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—COMT—autistic disorder	0.000374	0.000374	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—autistic disorder	0.000373	0.000373	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—MAOA—autistic disorder	0.000372	0.000372	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL5—autistic disorder	0.00037	0.00037	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—COMT—autistic disorder	0.000369	0.000369	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—autistic disorder	0.000367	0.000367	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CALCA—autistic disorder	0.000366	0.000366	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—autistic disorder	0.000357	0.000357	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PRKCB—autistic disorder	0.000356	0.000356	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—autistic disorder	0.000342	0.000342	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PIK3CG—autistic disorder	0.00034	0.00034	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—autistic disorder	0.000338	0.000338	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MAPK1—autistic disorder	0.000332	0.000332	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—autistic disorder	0.000324	0.000324	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRL—autistic disorder	0.000323	0.000323	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ACADSB—autistic disorder	0.00032	0.00032	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—INPP1—autistic disorder	0.00032	0.00032	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB2—autistic disorder	0.000306	0.000306	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AVP—autistic disorder	0.000288	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF2—autistic disorder	0.000287	0.000287	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—BTD—autistic disorder	0.000285	0.000285	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLA2G4A—autistic disorder	0.000271	0.000271	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—HRAS—autistic disorder	0.000267	0.000267	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—autistic disorder	0.000264	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MEF2C—autistic disorder	0.000263	0.000263	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITGB3—autistic disorder	0.000257	0.000257	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—autistic disorder	0.000255	0.000255	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TDO2—autistic disorder	0.000243	0.000243	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—autistic disorder	0.000242	0.000242	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HTR2A—autistic disorder	0.00024	0.00024	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—autistic disorder	0.000239	0.000239	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DHCR7—autistic disorder	0.000228	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TSC2—autistic disorder	0.000228	0.000228	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APOE—autistic disorder	0.000223	0.000223	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—autistic disorder	0.000223	0.000223	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—EXT1—autistic disorder	0.000216	0.000216	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC6A8—autistic disorder	0.000216	0.000216	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PRKCB—autistic disorder	0.00021	0.00021	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DAO—autistic disorder	0.000206	0.000206	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—APC—autistic disorder	0.000201	0.000201	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PIK3CG—autistic disorder	0.000201	0.000201	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGF—autistic disorder	0.000199	0.000199	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—UPB1—autistic disorder	0.000198	0.000198	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—autistic disorder	0.000191	0.000191	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IGF1—autistic disorder	0.000184	0.000184	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ASMT—autistic disorder	0.000184	0.000184	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM5—autistic disorder	0.000184	0.000184	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—MAPK1—autistic disorder	0.000183	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—autistic disorder	0.000175	0.000175	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC25A12—autistic disorder	0.000173	0.000173	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—SLC19A1—autistic disorder	0.000168	0.000168	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADSL—autistic disorder	0.00015	0.00015	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—HRAS—autistic disorder	0.000147	0.000147	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—XDH—autistic disorder	0.000147	0.000147	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—STX1A—autistic disorder	0.000144	0.000144	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NPAS2—autistic disorder	0.000144	0.000144	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—autistic disorder	0.000141	0.000141	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—autistic disorder	0.000141	0.000141	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TCN2—autistic disorder	0.000139	0.000139	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—autistic disorder	0.000133	0.000133	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADA—autistic disorder	0.000133	0.000133	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—RORA—autistic disorder	0.000121	0.000121	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MAOB—autistic disorder	0.000114	0.000114	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MAPK1—autistic disorder	0.000108	0.000108	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—TPH2—autistic disorder	0.000106	0.000106	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DPYD—autistic disorder	0.000104	0.000104	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CACNA1C—autistic disorder	9.66e-05	9.66e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DHFR—autistic disorder	8.79e-05	8.79e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRAS—autistic disorder	8.69e-05	8.69e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—autistic disorder	8.32e-05	8.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CYP19A1—autistic disorder	6.89e-05	6.89e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—COMT—autistic disorder	6.4e-05	6.4e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—autistic disorder	6.37e-05	6.37e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MAOA—autistic disorder	6.36e-05	6.36e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—autistic disorder	6.2e-05	6.2e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLA2G4A—autistic disorder	5.85e-05	5.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—autistic disorder	5.85e-05	5.85e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GPX1—autistic disorder	5.61e-05	5.61e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—MTHFR—autistic disorder	5.17e-05	5.17e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—APOE—autistic disorder	4.82e-05	4.82e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PIK3CG—autistic disorder	4.35e-05	4.35e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—autistic disorder	4.14e-05	4.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—autistic disorder	3.3e-05	3.3e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—autistic disorder	2.88e-05	2.88e-05	CbGpPWpGaD
